Cargando…

P1044: REDUCTION IN RED BLOOD CELL TRANSFUSION BURDEN: A NOVEL LONGITUDINAL TIME-DEPENDENT ANALYSIS IN PATIENTS WITH TRANSFUSION-DEPENDENT MYELOFIBROSIS TREATED WITH MOMELOTINIB

Detalles Bibliográficos
Autores principales: Harrison, Claire, Mesa, Ruben, Talpaz, Moshe, Gupta, Vikas, Gerds, Aaron T., Klencke, Barbara, Ellis, Catherine, Kawashima, Jun, Donahue, Rafe, Strouse, Bryan, Oh, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431508/
http://dx.doi.org/10.1097/01.HS9.0000971072.43107.6c
_version_ 1785091218809552896
author Harrison, Claire
Mesa, Ruben
Talpaz, Moshe
Gupta, Vikas
Gerds, Aaron T.
Klencke, Barbara
Ellis, Catherine
Kawashima, Jun
Donahue, Rafe
Strouse, Bryan
Oh, Stephen
author_facet Harrison, Claire
Mesa, Ruben
Talpaz, Moshe
Gupta, Vikas
Gerds, Aaron T.
Klencke, Barbara
Ellis, Catherine
Kawashima, Jun
Donahue, Rafe
Strouse, Bryan
Oh, Stephen
author_sort Harrison, Claire
collection PubMed
description
format Online
Article
Text
id pubmed-10431508
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104315082023-08-17 P1044: REDUCTION IN RED BLOOD CELL TRANSFUSION BURDEN: A NOVEL LONGITUDINAL TIME-DEPENDENT ANALYSIS IN PATIENTS WITH TRANSFUSION-DEPENDENT MYELOFIBROSIS TREATED WITH MOMELOTINIB Harrison, Claire Mesa, Ruben Talpaz, Moshe Gupta, Vikas Gerds, Aaron T. Klencke, Barbara Ellis, Catherine Kawashima, Jun Donahue, Rafe Strouse, Bryan Oh, Stephen Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431508/ http://dx.doi.org/10.1097/01.HS9.0000971072.43107.6c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Harrison, Claire
Mesa, Ruben
Talpaz, Moshe
Gupta, Vikas
Gerds, Aaron T.
Klencke, Barbara
Ellis, Catherine
Kawashima, Jun
Donahue, Rafe
Strouse, Bryan
Oh, Stephen
P1044: REDUCTION IN RED BLOOD CELL TRANSFUSION BURDEN: A NOVEL LONGITUDINAL TIME-DEPENDENT ANALYSIS IN PATIENTS WITH TRANSFUSION-DEPENDENT MYELOFIBROSIS TREATED WITH MOMELOTINIB
title P1044: REDUCTION IN RED BLOOD CELL TRANSFUSION BURDEN: A NOVEL LONGITUDINAL TIME-DEPENDENT ANALYSIS IN PATIENTS WITH TRANSFUSION-DEPENDENT MYELOFIBROSIS TREATED WITH MOMELOTINIB
title_full P1044: REDUCTION IN RED BLOOD CELL TRANSFUSION BURDEN: A NOVEL LONGITUDINAL TIME-DEPENDENT ANALYSIS IN PATIENTS WITH TRANSFUSION-DEPENDENT MYELOFIBROSIS TREATED WITH MOMELOTINIB
title_fullStr P1044: REDUCTION IN RED BLOOD CELL TRANSFUSION BURDEN: A NOVEL LONGITUDINAL TIME-DEPENDENT ANALYSIS IN PATIENTS WITH TRANSFUSION-DEPENDENT MYELOFIBROSIS TREATED WITH MOMELOTINIB
title_full_unstemmed P1044: REDUCTION IN RED BLOOD CELL TRANSFUSION BURDEN: A NOVEL LONGITUDINAL TIME-DEPENDENT ANALYSIS IN PATIENTS WITH TRANSFUSION-DEPENDENT MYELOFIBROSIS TREATED WITH MOMELOTINIB
title_short P1044: REDUCTION IN RED BLOOD CELL TRANSFUSION BURDEN: A NOVEL LONGITUDINAL TIME-DEPENDENT ANALYSIS IN PATIENTS WITH TRANSFUSION-DEPENDENT MYELOFIBROSIS TREATED WITH MOMELOTINIB
title_sort p1044: reduction in red blood cell transfusion burden: a novel longitudinal time-dependent analysis in patients with transfusion-dependent myelofibrosis treated with momelotinib
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431508/
http://dx.doi.org/10.1097/01.HS9.0000971072.43107.6c
work_keys_str_mv AT harrisonclaire p1044reductioninredbloodcelltransfusionburdenanovellongitudinaltimedependentanalysisinpatientswithtransfusiondependentmyelofibrosistreatedwithmomelotinib
AT mesaruben p1044reductioninredbloodcelltransfusionburdenanovellongitudinaltimedependentanalysisinpatientswithtransfusiondependentmyelofibrosistreatedwithmomelotinib
AT talpazmoshe p1044reductioninredbloodcelltransfusionburdenanovellongitudinaltimedependentanalysisinpatientswithtransfusiondependentmyelofibrosistreatedwithmomelotinib
AT guptavikas p1044reductioninredbloodcelltransfusionburdenanovellongitudinaltimedependentanalysisinpatientswithtransfusiondependentmyelofibrosistreatedwithmomelotinib
AT gerdsaaront p1044reductioninredbloodcelltransfusionburdenanovellongitudinaltimedependentanalysisinpatientswithtransfusiondependentmyelofibrosistreatedwithmomelotinib
AT klenckebarbara p1044reductioninredbloodcelltransfusionburdenanovellongitudinaltimedependentanalysisinpatientswithtransfusiondependentmyelofibrosistreatedwithmomelotinib
AT elliscatherine p1044reductioninredbloodcelltransfusionburdenanovellongitudinaltimedependentanalysisinpatientswithtransfusiondependentmyelofibrosistreatedwithmomelotinib
AT kawashimajun p1044reductioninredbloodcelltransfusionburdenanovellongitudinaltimedependentanalysisinpatientswithtransfusiondependentmyelofibrosistreatedwithmomelotinib
AT donahuerafe p1044reductioninredbloodcelltransfusionburdenanovellongitudinaltimedependentanalysisinpatientswithtransfusiondependentmyelofibrosistreatedwithmomelotinib
AT strousebryan p1044reductioninredbloodcelltransfusionburdenanovellongitudinaltimedependentanalysisinpatientswithtransfusiondependentmyelofibrosistreatedwithmomelotinib
AT ohstephen p1044reductioninredbloodcelltransfusionburdenanovellongitudinaltimedependentanalysisinpatientswithtransfusiondependentmyelofibrosistreatedwithmomelotinib